Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Found vs Médetone

By GLP-1 ScorecardUpdated

FoundFactor scores not reassessed.
Site position #7

Higher score

Médetone
Site position #425

Lower score

Score comparison

Found has the higher recorded score — 83.5/100 to 57.6/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Before you choose

Before comparing the headline prices, the Found review and the Médetone review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.

If neither one fits, Found vs MedLeanRx and Médetone vs No BS RX compare each of them with another graded program, and the list of alternatives to Found ranks the programs closest to Found on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueFound +47
78
31
Dose & formulationFound +11
94
83
Clinical oversightFound +26
86
60
Labs & monitoringFound +31
82
51
FulfillmentFound +15
84
69
Contract termsFound +3
70
67
Found · top barMédetone · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFoundMédetone
WeighScore83.5/10057.6/100
GradeBC
Site position#7#425
Semaglutide$149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)Brand Wegovy from $199/mo, Wegovy pill from $149/mo by dose (plus required membership: $29 first month, then $69/mo)
Tirzepatide$199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)Brand Zepbound from $299/mo by dose (plus required membership: $29 first month, then $69/mo)
CoverageU.S. service with state, treatment and insurance restrictions; confirm your eligibilityNot published
Brand-name accessYesYes
Oral / sublingualYesYes
Found

Site position #7 · B

Factor scores not reassessed.

Strengths

  • Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
  • Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
  • Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
  • Terms name possible independent medical groups and describe check-ins and messaging

What to consider

  • Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
  • Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
  • Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
  • Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
  • The assigned compounder, actual treating practice and individual license status remain unresolved
  • A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
Médetone

Site position #425 · C

Strengths

  • Publishes a cash price for every brand-name dose, including the Wegovy pill and Foundayo
  • Fills prescriptions through its own licensed pharmacy, which it names
  • Annual membership option for buyers who stay on treatment

What to consider

  • The required membership is billed on top of the medication price
  • Prices rise with each dose step
  • No refund once a physician review has begun
  • The prescribing medical group and states served are not published

Featured provider

Found

Factor scores not reassessed.

Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard